CPSC to Consider Proposed Rule on Certain OTC Child-Resistant Packaging
The Consumer Product Safety Commission has posted a briefing package and a draft proposed rule that would require child-resistant packaging for any over-the-counter or prescription drug product containing the equivalent of 0.08 milligrams or more of an imidazoline (tetrahydrozoline, naphazoline,…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
oxymetazoline, and xylometazoline) in a single package. Imidazolines are a family of drugs that are vasoconstrictors indicated for nasal congestion and/or ophthalmic irritation. The Commission is scheduled to vote on the draft proposed rule by January 18, 2012.